ReviewInflammopharmacology2023

Neuromodulation in Parkinson's disease targeting opioid and cannabinoid receptors, understanding the role of NLRP3 pathway: a novel therapeutic approach.

Md Reyaz Alam et al.PubMed ↗Publisher ↗

No numbers read from the abstract.